Zephyr Endobronchial Valve (EBV) System
FDA premarket approval P180002/S028 · decided 2024-08-23
Approval details
- PMA number
- P180002
- Supplement
- S028
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Zephyr Endobronchial Valve (EBV) System
- Generic name
- Valve, pulmonary
- Applicant
- Pulmonx Corporation
- Date received
- 2024-07-26
- Decision date
- 2024-08-23
- Days to decision
- 28 days
- Decision code
- OK30
- Product code
- NJK
- Advisory committee
- Anesthesiology
- Expedited review
- No
- Location
- Redwood City, CA
- Statement
- A manufacturing change from two cycles of ethylene oxide (EO) sterilization to three cycles of ethylene oxide sterilization with a three-year shelf life for two lots of the Zephyr 4.0-LP EBV (Lot 506377-V7.1 and Lot 506412-V7.1).
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Chartis Precision Catheter (K253096) | Pulmonx Corporation | 2026-02-13 |
| Chartis Precision Catheter (K222340) | Pulmonx Corporation | 2022-12-01 |
| Lung Image Analysis (K212494) | Pulmonx Corporation | 2021-09-02 |
| Pulmonx Chartis Tablet Console (K180011) | Pulmonx Corporation | 2018-07-13 |